Adult ADHD Self-Report Scale (ASRS-v1.1) symptom checklist in patients with substance use disorders

Authors

  • C. Daigre Psychiatry Department Hospital Universitari Vall d’Hebron Universidad Autónoma de Barcelona Barcelona (Spain); Outpatients Drug Nuit (CAS) of Vall d’Hebron Barcelona (Spain)
  • J. A. Ramos-Quiroga Psychiatry Department Hospital Universitari Vall d’Hebron Universidad Autónoma de Barcelona Barcelona (Spain)
  • S. Valero Psychiatry Department Hospital Universitari Vall d’Hebron Universidad Autónoma de Barcelona Barcelona (Spain)
  • R. Bosch Psychiatry Department Hospital Universitari Vall d’Hebron Universidad Autónoma de Barcelona Barcelona (Spain)
  • C. Roncero Psychiatry Department Hospital Universitari Vall d’Hebron Universidad Autónoma de Barcelona Barcelona (Spain); Outpatients Drug Nuit (CAS) of Vall d’Hebron Barcelona (Spain)
  • B. Gonzalvo Psychiatry Department Hospital Universitari Vall d’Hebron Universidad Autónoma de Barcelona Barcelona (Spain); Outpatients Drug Nuit (CAS) of Vall d’Hebron Barcelona (Spain)
  • M. Nogueira sychiatry Department Hospital Universitari Vall d’Hebron Universidad Autónoma de Barcelona Barcelona (Spain)
  • M. Casas Psychiatry Department Hospital Universitari Vall d’Hebron Universidad Autónoma de Barcelona Barcelona (Spain)

Keywords:

ASRS-v1.1, ADHD, Attention deficit/hyperactivity disorder, Substance use disorder, Addiction, Screening

Abstract

Aim. Diagnosing attention deficit/hyperactivity disorder (ADHD) in patients with substance use disorder (SUD) is a complicated process in which a screening tool may be useful. We analyzed the ASRS-v1.1 validity in patients with SUD, considering the addiction severity and co-morbidity with depressive disorders, antisocial and borderline personality.

Methods. Eighty outpatients with SUD were evaluated with the following instruments: ASRS-v1.1, CAAD-II, Euro-pASI, SCID-I, SCID-II. A factor analysis was performed with Varimax rotation to determine the structure of the intercorrelations among the items. Accuracy of ASRS-v1.1 was also analyzed.

Results. The diagnostic interview CAADID used as a gold standard indicated that 20% (95% confidence interval [CI]: 11-29) meet the criteria for ADHD. The ASRS-v1.1 factor structure is marked by two factors related to inattention and hyperactivity / impulsivity that account for 67.7% of the variance. ASRS-v1.1, with a 4 cut-off, showed an 87.5% sensitivity and 68.6% specificity.

Conclusions. ASRS-v1.1 is a simple screening tool that is useful and has acceptable validity for the identification of ADHD among addicted patients.

Downloads

Published

2009-11-01

How to Cite

Daigre, C., et al. “Adult ADHD Self-Report Scale (ASRS-v1.1) Symptom Checklist in Patients With Substance Use Disorders”. Actas Españolas De Psiquiatría, vol. 37, no. 6, Nov. 2009, pp. 299-05, https://actaspsiquiatria.es/index.php/actas/article/view/1122.

Issue

Vol. 37 No. 6 (2009)

Section

Original